Although more than 10 new antiepileptic drugs have been
developed in the past decade, epilepsy remains resistant to drug
therapy in about one third of patients, many of whom struggle with
the disease their entire lives. Managing these patients is a
challenge and requires a structured multidisciplinary approach. The
book includes chapters on all issues related to pharmacoresistance
in epilepsy and describes recent developments in the pathogenesis
and treatment of this disorder. It addresses abnormalities in
inhibitory mechanisms, epilepsy-related changes to the immune
system, development of pharmacoresistance caused by chronic
exposure to antiepileptic drugs, and novel therapeutic strategies
for preventing or slowing down the progression of the disease.
Clinicians and basic scientists alike will find up-to-date
information on the development of pharmacoesistance, as well as
reviews of mechanisms associated with epilepsy that may help them
consider novel strategies for preventing the development of
pharmacoresistance in the first place. The book also features
information on new therapeutic strategies for control of epilepsy,
such as transcutaneous electrical stimulation and virtual screening
of new antiepileptic drugs. "Pharmacoresistance in Epilepsy" " From
Genes and Molecules to Promising Therapies" is useful to anyone
working in the field, whether they re studying epilepsy in the lab
or treating it in a doctor s office. "
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!